.jpg)
.png)
All
Extreme hypertriglyceridemia, defined as triglyceride (TG) levels ≥1000 mg/dL, is almost always indicative of chylomicronemia. The current diagnostic approach categorizes individuals with chylomicronemia into familial chylomicronemia syndrome (FCS; prevalence 1–10 per million), caused by the... more
Historically, familial hypercholesterolemia (FH), remains an underdiagnosed and undertreated disease. It is estimated that 90% of individuals with FH remain undiagnosed in the United States.(1) FH patients have ten to twenty-fold higher risk of cardiovascular disease. However, cardiovascular risk... more
The National Lipid Association announced on Wednesday its support of the Lipoprotein(a) Foundation’s efforts to promote a new ICD-10 Diagnostic-Code for high Lp(a). The NLA believes the new code will be beneficial in identifying lethal risk factors in patients. To further support this... more
BACKGROUND: Primiparity has been associated with 3 to 4 mg/dL lower high-density lipoprotein cholesterol concentrations in black and white adult women that persist several years after delivery. OBJECTIVE: To examine the lasting effects of adolescent pregnancy on blood lipids, an early risk... more
The National Lipid Association is sad to report that Gumaro Garza, MD, an active member of the Southwest Lipid Association, passed away July 29, 2014, after suffering a myocardial infarction and subsequent cardiogenic shock. Garza resided in Edinberg, Texas, and was very active in the treatment of... more
The Foundation of the NLA did something a little different this year – instead of hosting a black-tie gala event, we opted for a more casual affair, filled with light bites and vintage arcade games! The evening was full of good conversation, and friendly competition. We appreciate those who made it... more
Esperion has announced that NEXLETOL™ (bempedoic acid) is now available in pharmacies in the United States. NEXLETOL is an oral, once-daily, tablet indicated as an adjunct to diet and maximally tolerated statin for the treatment of adults with heterozygous familial hypercholesterolemia (HeFH... more
Registration Open for the NLA Scientific Sessions Register for the National Lipid Association’s annual Scientific Sessions May 18–21, 2017, at the Philadelphia Marriott Downtown. Don’t miss featured sessions on: Genetic Scoring and Cardiovascular Risk, Treatment and Developing... more
As a professional organization, the National Lipid Association's mission has been to reduce the morbidity and mortality from cardiovascular disease by increasing the understanding of the pathophysiology, and detection and optimal treatment of lipid disorders. Developing patient... more
In >95% of patients, high triglycerides reflect the burden of the effects of more than 30 genes involved in triglyceride pathways Published in Lancet Diabetes & Endocrinology,1 Free to download from 31 January – 28 February 2014 at http://www.thelancet.com/journals/landia/article/... more